CCL18 and Duchenne muscular dystrophy: As shown in Figure 5, both CCL2 and CCL18 declined with age in DMD patients (age range: 4–29 years old, n = 26, p-value < 0.05) while CXCL10 remained unchanged over time with age (n = 25, p-value = 0.3952) in agreement with our earlier study [18].